Cargando…

KOC is a novel molecular indicator of malignancy

The detection of malignant cells in fine-needle aspirates (FNA's) using marker genes is hampered by the fact that these markers are only expressed by certain malignancies or lack sensitivity and/or specificity. Here we report the results of a prospective pilot study examining the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, F, Bommer, M, Lacher, U, Ruhland, C, Stagge, V, Adler, G, Gress, T M, Seufferlein, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376347/ https://www.ncbi.nlm.nih.gov/pubmed/12618877 http://dx.doi.org/10.1038/sj.bjc.6600790

Ejemplares similares

Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling
por: Lee, Y-F, et al.
Publicado: (2003)

Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy
por: Lambert, D W, et al.
Publicado: (2002)

Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis
por: Offersen, B V, et al.
Publicado: (2002)

Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1
por: Ebert, M P A, et al.
Publicado: (2002)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker
por: Salazar-Onfray, F, et al.
Publicado: (2002)

The prognostic influence of bcl-2 in malignant glioma
por: McDonald, F E, et al.
Publicado: (2002)

Lymphatic density and metastatic spread in human malignant melanoma
por: Shields, J D, et al.
Publicado: (2004)

Purified malignant mammary epithelial cells maintain hormone responsiveness in culture
por: Kothari, M S, et al.
Publicado: (2003)

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
por: Hiyama, E, et al.
Publicado: (2004)

The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer
por: Kato, T, et al.
Publicado: (2003)

Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
por: Langelotz, C, et al.
Publicado: (2003)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
por: Vivo, C, et al.
Publicado: (2003)

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
por: Rohloff, J, et al.
Publicado: (2002)

Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27
por: O'Neill, P A, et al.
Publicado: (2004)

Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas
por: Kikuchi, R, et al.
Publicado: (2002)

Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression
por: Strieth, S, et al.
Publicado: (2002)

An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue
por: Abe, N, et al.
Publicado: (2003)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer
por: Kronqvist, P, et al.
Publicado: (2002)

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
por: Michalides, R, et al.
Publicado: (2002)

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence
por: Jirström, K, et al.
Publicado: (2003)

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003)

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
por: Arango, D, et al.
Publicado: (2004)

Allelic loss at 19q12 and Xq11–12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential
por: Nakayama, K, et al.
Publicado: (2004)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women
por: Masumoto, N, et al.
Publicado: (2003)

Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells
por: Hövelmann, S, et al.
Publicado: (2004)

Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis
por: Gasbarri, A, et al.
Publicado: (2004)

Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system
por: Bøe, A S, et al.
Publicado: (2004)

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002)

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
por: Koukourakis, M I, et al.
Publicado: (2003)

Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients
por: Temam, S, et al.
Publicado: (2003)

Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes
por: Mitas, M, et al.
Publicado: (2002)

A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens
por: Scott, I S, et al.
Publicado: (2004)

Sentinel lymph-node biopsy in head and neck cancer
por: Höft, S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_d4j0rcqi9mnfeh752ne1b37evq